Evaluating the impact of a structured medication optimisation review on prescribing patterns and bleeding risk among patients prescribed direct oral anticoagulants (DOACs): a difference-in-differences study. [PDF]
BMJ Open QualCamacho EM +7 more
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi +6 more
wiley +1 more source
Implementation of an integrative safety consultation service for the use of dietary and herbal supplements among patients with hematological diseases. [PDF]
Support Care CancerLevy Yurkovski I +7 more
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1346-1357, April 2025.Abstract Aims Iron deficiency (ID) is prevalent in chronic heart failure (HF) but lacks a consensus definition. This study evaluates the prevalence and the prognostic impact of ID using different criteria on all‐cause and cardiovascular mortality, as well as first hospitalization for HF in patients with new‐onset chronic HF.
Abdullahi Ahmed Mohamed +12 more
wiley +1 more source
FDG PET/CT imaging and circulating biomarkers of inflammation in desmoplakin cardiomyopathy
ESC Heart Failure, Volume 12, Issue 2, Page 1485-1489, April 2025.Abstract Aims Inflammation has been implicated in the pathogenesis of desmoplakin (DSP) cardiomyopathy, and retrospective studies have described abnormal myocardial fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) findings in symptomatic patients eventually diagnosed with DSP cardiomyopathy.
Sanjay Divakaran +10 more
wiley +1 more source
Current clinical research status and future treatment directions for liver cirrhosis combined with portal vein thrombosis. [PDF]
World J HepatolHe WL, Yan S, Lu JJ, Chen L, Wu JZ.
europepmc +1 more source
Mid‐term survival in patients awaiting heart and kidney transplantation with Impella 5.5 support
ESC Heart Failure, EarlyView.Abstract Background Patients with end‐stage heart failure and chronic kidney disease requiring dual‐organ transplantation (DOT) face significant challenges in utilizing durable mechanical circulatory support due to the risks associated with renal replacement therapies (RRTs) and multi‐organ failure.
Smruti Desai +12 more
wiley +1 more source
Direct Oral Anticoagulants or Warfarin for Left Ventricular Thrombus: A Meta-Analysis of Randomized Clinical Trials. [PDF]
JACC AdvKoeckerling D +7 more
europepmc +1 more source
Use of glucagon‐like peptide‐1 receptor agonists in patients with left ventricular assist devices
ESC Heart Failure, EarlyView.Key question: does GLP1‐RA therapy improve heart transplantation rates and clinical outcomes in patients with LVADs? Key findings: in this propensity score‐matched cohort study of 1068 LVAD recipients, GLP1‐RA use was associated with higher heart transplantation rates (18.9% vs.
Ramzi Ibrahim +12 more
wiley +1 more source
Antiretroviral therapy and associated drug interactions with cardiovascular drugs: a critical review. [PDF]
Front PharmacolSpanakis M, Alexakis K, Ioannou P.
europepmc +1 more source